Abbott Buyback
OLI recorded this information on 9/11/2014
Company:
Abbott
Buyback:
ABT buyback
$Amount Authorized:
$3,000,000,000
Buyback Details:
Abbott's board has authorized the repurchase of up to $3 billion of the corporation's common shares. This new authorization is in addition to the $511 million unused portion of the previous program that was announced in June 2013. The purchases may be made from time to time as market conditions warrant and subject to regulatory considerations.
Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a line of health care products. Co. has four segments: Established Pharmaceutical Products, which includes a line of generic pharmaceuticals; Diagnostic Products, which includes a line of diagnostic systems and tests; Nutritional Products, which includes a line of pediatric and adult nutritional products; and Medical Devices, which includes a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders.
Abbott Laboratories SEC Filing Email Alerts Service
Open the ABT Page at The Online Investor »
|
Open the ABT Page at The Online Investor (in a new window) »
Free ABT Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Buy (3.47 out of 4) 55th percentile
(ranked higher than approx. 55% of all stocks covered)
Analysts' Target Price: ABT Stock Forecast Based on Zacks ABR data; powered by Xignite |